Words of wisdom. Re: Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.

Eur Urol

Service of Urology, Instituto Valenciano de Oncología, Valencia, Spain. Electronic address:

Published: April 2014

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.eururo.2013.12.034	DOI Listing

Publication Analysis

wisdom final

final eortc-gu

eortc-gu cancers

cancers group

group randomized

randomized study

study maintenance

maintenance bacillus

bacillus calmette-guérin

calmette-guérin intermediate-

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!